Droxidopa is an amino acid precursor to norepinephrine, approved for the treatment of neurogenic orthostatic hypotension in adults with primary autonomic failure. It is converted t...
Droxidopa is an amino acid precursor to norepinephrine, approved for the treatment of neurogenic orthostatic hypotension in adults with primary autonomic failure. It is converted to norepinephrine peripherally, raising blood pressure on standing.
| Parameter | Specification |
|---|---|
| Chemical Name | Droxidopa |
| CAS Number | 23651-95-8 |
| Molecular Formula | C₉H₁₁NO₅ |
| Molecular Weight | 213.19 g/mol |
| Purity | ≥ 99.5% |
| Appearance | White crystalline powder |
| Solubility | Slightly soluble in water; soluble in dilute hydrochloric acid |
| Grade | Pharmaceutical Grade (USP) |
| Storage | Store at room temperature, protect from light |
| Batch Size | 10 grams to 250 kg lots |
| Available Documentation | CoA, CoO, DMF, MSDS |
Patent Notice: Products under patents are offered subject to the patent laws of the importing countries. The buyer is solely responsible for compliance with patent rights in any specific country.